Page last updated: 2024-11-12

kealiinine a

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

kealiinine A: from the marine sponge Leucetta chagosensis; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID9997944
CHEMBL ID488196
MeSH IDM0582043

Synonyms (3)

Synonym
CHEMBL488196
kealiinine a
2-amino-6-methoxy-9-(4-methoxyphenyl)-3-methylbenzo[f]benzimidazol-7-ol
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (4)

Assay IDTitleYearJournalArticle
AID401945Antifungal activity against Cladosporium herbarum DSM 63422 at 20 ug/disk after 24 hrs by agar plate diffusion assay2004Journal of natural products, May, Volume: 67, Issue:5
New imidazole alkaloids from the Indonesian sponge Leucetta chagosensis.
AID780097Cytotoxicity against human MCF7 cells after 96 hrs by MTT assay2013Bioorganic & medicinal chemistry letters, Nov-15, Volume: 23, Issue:22
Total syntheses and cytotoxicity of kealiiquinone, 2-deoxy-2-aminokealiiquinone and analogs.
AID401944Toxicity in Artemia salina at 20 ug/mL2004Journal of natural products, May, Volume: 67, Issue:5
New imidazole alkaloids from the Indonesian sponge Leucetta chagosensis.
AID1435057Cytotoxicity against human MCF7 cells assessed as growth inhibition after 96 hrs by MTT assay2017Bioorganic & medicinal chemistry, 03-01, Volume: 25, Issue:5
Total synthesis and cytotoxicity of Leucetta alkaloids.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (20.00)29.6817
2010's4 (80.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other5 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]